Evidence map›Paper›PMID 26503226›Full record

ArticleMolecular brain2015

Transcription factor CREB3L1 mediates cAMP and glucocorticoid regulation of arginine vasopressin gene transcription in the rat hypothalamus.

Mingkwan Greenwood, Michael P Greenwood, Andre S Mecawi, Su Yi Loh, José Antunes Rodrigues, Julian F R Paton, David Murphy

Open access · goldAbstract read
In one paragraph

Article in Molecular brain, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Mingkwan GreenwoodSchool of Clinical Sciences, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol, BS1 3NY, England. mingkwan.greenwood@bristol.ac.uk.
Michael P GreenwoodSchool of Clinical Sciences, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol, BS1 3NY, England. mike.greenwood@bristol.ac.uk.
Andre S MecawiSchool of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil. mecawi.as@gmail.com.
Su Yi LohDepartment of Physiology, University of Malaya, Kuala Lumpur, 50603, Malaysia. suyi91189@hotmail.com.
José Antunes RodriguesSchool of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil. jantunesr@gmail.com.
Julian F R PatonSchool of Physiology and Pharmacology, University of Bristol, Bristol, BS8 1TD, England. Julian.F.R.Paton@bristol.ac.uk.
David MurphySchool of Clinical Sciences, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol, BS1 3NY, England. d.murphy@bristol.ac.uk.
University of Bristol · GBUniversidade de Ribeirão Preto · BRUniversity of Malaya · MY

Funding

Biotechnology and Biological Sciences Research Council BB/G006156/1Biotechnology and Biological Sciences Research Council BB/J015415/1Medical Research Council G0700954
6 · The paper itself

Abstract

backgroundArginine vasopressin (AVP), a neuropeptide hormone that functions in the regulation of water homeostasis by controlling water re-absorption at kidneys, is synthesised in supraoptic nucleus and paraventricular nucleus of the hypothalamus. An increase in plasma osmolality stimulates secretion of AVP to blood circulation and induces AVP synthesis in these nuclei. Although studies on mechanism of AVP transcriptional regulation in hypothalamus proposed that cAMP and glucocorticoids positively and negatively regulate Avp expression, respectively, the molecular mechanisms have remained elusive. Recently, we identified CREB3L1 (cAMP-responsive element binding protein 3 like 1) as a putative transcription factor of Avp transcription in the rat hypothalamus. However the mechanism of how CREB3L1 is regulated in response of hyperosmotic stress in the neurons of hypothalamus has never been reported. This study aims to investigate effect of previously reported regulators (cAMP and glucocorticoid) of Avp transcription on transcription factor CREB3L1 in order to establish a molecular explanation for cAMP and glucocorticoids effect on AVP expression.

resultsThe effect of cAMP and glucocorticoid treatment on Creb3l1 was investigated in both AtT20 cells and hypothalamic organotypic cultures. The expression of Creb3l1 was increased in both mRNA and protein level by treatment with forskolin, which raises intracellular cAMP levels. Activation of cAMP by forskolin also increased Avp promoter activity in AtT20 cells and this effect was blunted by shRNA mediated silencing of Creb3l1. The forskolin induced increase in Creb3l1 expression was diminished by combined treatment with dexamethasone, and, in vivo, intraperitoneal dexamethasone injection blunted the increase in Creb3l1 and Avp expression induced by hyperosmotic stress.

conclusionHere we shows that cAMP and glucocorticoid positively and negatively regulate Creb3l1 expression in the rat hypothalamus, respectively, and regulation of cAMP on AVP expression is mediated through CREB3L1. This data provides the connection between CREB3L1, a newly identified transcription factor of AVP expression, with the previously proposed mechanism of Avp transcription which extends our understanding in transcription regulation of Avp in the hypothalamus.

Indexed as

AnimalsArginine VasopressinColforsinCyclic AMPCyclic AMP Response Element-Binding ProteinDexamethasoneGene Expression RegulationGlucocorticoidsHypothalamusMaleOrgan Culture TechniquesOsmotic PressureParaventricular Hypothalamic NucleusPromoter Regions, GeneticRats, Sprague-DawleyStress, PhysiologicalArginine VasopressinColforsinCREB3L1 protein, ratCyclic AMPCyclic AMP Response Element-Binding ProteinDexamethasoneGlucocorticoids

Identifiers

PMID26503226
PMCPMC4624382
OpenAlexW1951464467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.